TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL PSYCHOTROPIC DRUGS MARKET, BY DRUG TYPE
6.1. Overview
6.2. Chlorpromazine
6.3. Thioridazine
6.4. Quetiapine
6.5. Risperidone
6.6. Others
7. GLOBAL PSYCHOTROPIC DRUGS MARKET, BY APPLICATION
7.1. Overview
7.2. Anti-psychotics
7.3. Antidepressants
7.4. Mood Stabilizers (MS)
7.5. Anti-anxiety
7.6. Others
8. GLOBAL PSYCHOTROPIC DRUGS MARKET, BY DISTRIBUTION CHANNEL
8.1. Overview
8.2. Hospital Pharmacies
8.3. Retail Pharmacies
8.4. Online Pharmacies
8.5. Drug Stores
9. GLOBAL PSYCHOTROPIC DRUGS MARKET, BY REGION
9.1. Overview
9.1. North America
9.1.1. US
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. France
9.2.3. UK
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia-Pacific
9.3.1. China
9.3.2. India
9.3.3. Japan
9.3.4. South Korea
9.3.5. Australia
9.3.6. Rest of Asia-Pacific
9.4. Rest of the World
9.4.1. Middle East
9.4.2. Africa
9.4.3. Latin America
10. COMPETITIVE LANDSCAPE
10.1. Overview
10.2. Competitive Analysis
10.3. Market Share Analysis
10.4. Major Growth Strategy in the Global Psychotropic Drugs Market,
10.5. Competitive Benchmarking
10.6. Leading Players in Terms of Number of Developments in the Global Psychotropic Drugs Market,
10.7. Key developments and Growth Strategies
10.7.1. New Product Launch/Service Deployment
10.7.2. Merger & Acquisitions
10.7.3. Joint Ventures
10.8. Major Players Financial Matrix
10.8.1. Sales & Operating Income, 2022
10.8.2. Major Players R&D Expenditure. 2022
11. COMPANY PROFILES
11.1. Forest Laboratories
11.1.1. Company Overview
11.1.2. Financial Overview
11.1.3. Products Offered
11.1.4. Key Developments
11.1.5. SWOT Analysis
11.1.6. Key Strategies
11.2. Sun Pharmaceutical Industries Ltd.
11.2.1. Company Overview
11.2.2. Financial Overview
11.2.3. Products Offered
11.2.4. Key Developments
11.2.5. SWOT Analysis
11.2.6. Key Strategies
11.3. FUJIFILM Wako Pure Chemical Corporation
11.3.1. Company Overview
11.3.2. Financial Overview
11.3.3. Products Offered
11.3.4. Key Developments
11.3.5. SWOT Analysis
11.3.6. Key Strategies
11.4. Randox Laboratories Ltd
11.4.1. Company Overview
11.4.2. Financial Overview
11.4.3. Products Offered
11.4.4. Key Developments
11.4.5. SWOT Analysis
11.4.6. Key Strategies
11.5. Pfizer Inc.
11.5.1. Company Overview
11.5.2. Financial Overview
11.5.3. Products Offered
11.5.4. Key Developments
11.5.5. SWOT Analysis
11.5.6. Key Strategies
11.6. Ely Lilly
11.6.1. Company Overview
11.6.2. Financial Overview
11.6.3. Products Offered
11.6.4. Key Developments
11.6.5. SWOT Analysis
11.6.6. Key Strategies
11.7. Mylan N.V
11.7.1. Company Overview
11.7.2. Financial Overview
11.7.3. Products Offered
11.7.4. Key Developments
11.7.5. SWOT Analysis
11.7.6. Key Strategies
11.8. Otsuka Pharmaceutical Co. Ltd.
11.8.1. Company Overview
11.8.2. Financial Overview
11.8.3. Products Offered
11.8.4. Key Developments
11.8.5. SWOT Analysis
11.8.6. Key Strategies
11.9. Alkermes Plc
11.9.1. Company Overview
11.9.2. Financial Overview
11.9.3. Products Offered
11.9.4. Key Developments
11.9.5. SWOT Analysis
11.9.6. Key Strategies
12. APPENDIX
12.1. References
12.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL PSYCHOTROPIC DRUGS MARKET, SYNOPSIS, 2018-2032
TABLE 2 GLOBAL PSYCHOTROPIC DRUGS MARKET, ESTIMATES & FORECAST, 2018-2032 (USD BILLION)
TABLE 3 GLOBAL PSYCHOTROPIC DRUGS MARKET, BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 4 GLOBAL PSYCHOTROPIC DRUGS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 5 GLOBAL PSYCHOTROPIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 6 NORTH AMERICA: PSYCHOTROPIC DRUGS MARKET, BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 7 NORTH AMERICA: PSYCHOTROPIC DRUGS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 8 NORTH AMERICA: PSYCHOTROPIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 9 US: PSYCHOTROPIC DRUGS MARKET, BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 10 US: PSYCHOTROPIC DRUGS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 11 US: PSYCHOTROPIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 12 CANADA: PSYCHOTROPIC DRUGS MARKET, BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 13 CANADA: PSYCHOTROPIC DRUGS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 14 CANADA: PSYCHOTROPIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 1 EUROPE: PSYCHOTROPIC DRUGS MARKET, BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 2 EUROPE: PSYCHOTROPIC DRUGS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 3 EUROPE: PSYCHOTROPIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 4 GERMANY: PSYCHOTROPIC DRUGS MARKET, BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 5 GERMANY: PSYCHOTROPIC DRUGS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 6 GERMANY: PSYCHOTROPIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 7 FRANCE: PSYCHOTROPIC DRUGS MARKET, BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 8 FRANCE: PSYCHOTROPIC DRUGS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 9 FRANCE: PSYCHOTROPIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 10 ITALY: PSYCHOTROPIC DRUGS MARKET, BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 11 ITALY: PSYCHOTROPIC DRUGS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 12 ITALY: PSYCHOTROPIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 13 SPAIN: PSYCHOTROPIC DRUGS MARKET, BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 14 SPAIN: PSYCHOTROPIC DRUGS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 15 SPAIN: PSYCHOTROPIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 16 UK: PSYCHOTROPIC DRUGS MARKET, BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 17 UK: PSYCHOTROPIC DRUGS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 18 UK: PSYCHOTROPIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 19 REST OF EUROPE: PSYCHOTROPIC DRUGS MARKET, BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 20 REST OF EUROPE: PSYCHOTROPIC DRUGS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 21 REST OF EUROPE: PSYCHOTROPIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 22 ASIA-PACIFIC: PSYCHOTROPIC DRUGS MARKET, BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 23 ASIA-PACIFIC: PSYCHOTROPIC DRUGS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 24 ASIA-PACIFIC: PSYCHOTROPIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 25 JAPAN: PSYCHOTROPIC DRUGS MARKET, BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 26 JAPAN: PSYCHOTROPIC DRUGS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 27 JAPAN: PSYCHOTROPIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 28 CHINA: PSYCHOTROPIC DRUGS MARKET, BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 29 CHINA: PSYCHOTROPIC DRUGS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 30 CHINA: PSYCHOTROPIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 31 INDIA: PSYCHOTROPIC DRUGS MARKET, BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 32 INDIA: PSYCHOTROPIC DRUGS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 33 INDIA: PSYCHOTROPIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 34 AUSTRALIA: PSYCHOTROPIC DRUGS MARKET, BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 35 AUSTRALIA: PSYCHOTROPIC DRUGS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 36 AUSTRALIA: PSYCHOTROPIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 37 SOUTH KOREA: PSYCHOTROPIC DRUGS MARKET, BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 38 SOUTH KOREA: PSYCHOTROPIC DRUGS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 39 SOUTH KOREA: PSYCHOTROPIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 40 REST OF ASIA-PACIFIC: PSYCHOTROPIC DRUGS MARKET, BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 41 REST OF ASIA-PACIFIC: PSYCHOTROPIC DRUGS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 42 REST OF ASIA-PACIFIC: PSYCHOTROPIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 43 REST OF THE WORLD: PSYCHOTROPIC DRUGS MARKET, BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 44 REST OF THE WORLD: PSYCHOTROPIC DRUGS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 45 REST OF THE WORLD: PSYCHOTROPIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 46 MIDDLE EAST: PSYCHOTROPIC DRUGS MARKET, BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 47 MIDDLE EAST: PSYCHOTROPIC DRUGS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 48 MIDDLE EAST: PSYCHOTROPIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 49 AFRICA: PSYCHOTROPIC DRUGS MARKET, BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 50 AFRICA: PSYCHOTROPIC DRUGS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 51 AFRICA: PSYCHOTROPIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 52 LATIN AMERICA: PSYCHOTROPIC DRUGS MARKET, BY DRUG TYPE, 2018-2032 (USD BILLION)
TABLE 53 LATIN AMERICA: PSYCHOTROPIC DRUGS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 54 LATIN AMERICA: PSYCHOTROPIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL PSYCHOTROPIC DRUGS MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL PSYCHOTROPIC DRUGS MARKET
FIGURE 4 GLOBAL PSYCHOTROPIC DRUGS MARKET, SHARE (%), BY DRUG TYPE, 2022
FIGURE 5 GLOBAL PSYCHOTROPIC DRUGS MARKET, SHARE (%), BY APPLICATION, 2022
FIGURE 6 GLOBAL PSYCHOTROPIC DRUGS MARKET, SHARE (%), BY DISTRIBUTION CHANNEL, 2022
FIGURE 7 GLOBAL PSYCHOTROPIC DRUGS MARKET, SHARE (%), BY REGION, 2022
FIGURE 8 NORTH AMERICA: PSYCHOTROPIC DRUGS MARKET, SHARE (%), BY REGION, 2022
FIGURE 9 EUROPE: PSYCHOTROPIC DRUGS MARKET, SHARE (%), BY REGION, 2022
FIGURE 10 ASIA-PACIFIC: PSYCHOTROPIC DRUGS MARKET, SHARE (%), BY REGION, 2022
FIGURE 11 REST OF THE WORLD: PSYCHOTROPIC DRUGS MARKET, SHARE (%), BY REGION, 2022
FIGURE 12 GLOBAL PSYCHOTROPIC DRUGS MARKET: COMPANY SHARE ANALYSIS, 2022 (%)
FIGURE 13 FOREST LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 14 FOREST LABORATORIES: SWOT ANALYSIS
FIGURE 15 SUN PHARMACEUTICAL INDUSTRIES LTD.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 16 SUN PHARMACEUTICAL INDUSTRIES LTD.: SWOT ANALYSIS
FIGURE 17 FUJIFILM WAKO PURE CHEMICAL CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 18 FUJIFILM WAKO PURE CHEMICAL CORPORATION: SWOT ANALYSIS
FIGURE 19 FUJIFILM WAKO PURE CHEMICAL CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 20 FUJIFILM WAKO PURE CHEMICAL CORPORATION: SWOT ANALYSIS
FIGURE 21 RANDOX LABORATORIES LTD.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 22 RANDOX LABORATORIES LTD.: SWOT ANALYSIS
FIGURE 23 PFIZER INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 24 PFIZER INC.: SWOT ANALYSIS
FIGURE 25 ELY LILLY: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 26 ELY LILLY: SWOT ANALYSIS
FIGURE 27 MYLAN N.V: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 28 MYLAN N.V: SWOT ANALYSIS
FIGURE 29 OTSUKA PHARMACEUTICAL CO. LTD.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 30 OTSUKA PHARMACEUTICAL CO. LTD.: SWOT ANALYSIS
FIGURE 31 ALKERMES PLC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 32 ALKERMES PLC: SWOT ANALYSIS
